StoryFunding
Adisseo ends financial support for Calysseo as the FeedKind plant in Chongqing stays suspended
CalystaFeedKind (Chongqing plant)
Bluestar Adisseo said it will give no more financial help to Calysseo, its 50:50 joint venture with Calysta. The Chongqing plant, the first large-scale demonstration of single-cell protein, has suspended production and needs funding for technical upgrades to reach its design standard.
- Adisseo had approved a shareholder loan of up to US$16.25M in Feb 2025
- The JV cites a severe working-capital shortage from R&D complexity and scale-up problems
- Calysseo's unaudited 2025 results: US$0.71M revenue, US$15.5M net loss